Danaher Corporation (DHR) is a Healthcare · Diagnostics & Research company listed on NYSE. Price $211.81 (-0.32%), Market cap $121.11B, P/E ratio 33.10, 52-week low–high $161.91 ~ $242.05.
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and
Financial statements, price targets, institutional (13F) holdings and related news for Danaher Corporation are updated in real time on BlackAll Trade.
Danaher Corporation trades at $211.81 (-0.32%). Real-time quotes and charts are available on BlackAll Trade.
Danaher Corporation has a market cap of about $121.11B. Its P/E ratio is 33.10.
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates thro